Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MDM2 is a nucleo-phosphoprotein involved in oncogenesis by binding p53.
• MDM2 possesses domains suggesting nucleic acid binding capabilities.
• Previous studies indicated MDM2 binds RNA, but DNA binding remained unexamined.

Purpose of the Study:

• To investigate the DNA binding capacity of bacterially expressed human MDM2.
• To characterize the DNA binding specificity and domain involvement of MDM2.
• To compare DNA and RNA binding mechanisms of MDM2.

Main Methods:

• Bacterial expression of human MDM2 protein.
• DNA and RNA binding assays.
• Antibody inhibition assay for RNA binding.
• Selection cloning and sequence analysis of DNA binding sites.

Main Results:

• Bacterially expressed MDM2 binds both DNA and RNA.
• MDM2 DNA binding is selective for oligopurine:pyrimidine-rich sequences.
• DNA binding involves the carboxy-terminal domain, distinct from RNA binding.
• An MDM2-specific antibody inhibited RNA binding.

Conclusions:

• MDM2 exhibits dual DNA and RNA binding capabilities.
• Preferential DNA binding may involve Zinc Finger or Ring Finger domains.
• MDM2 likely employs different mechanisms for DNA and RNA binding.